This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.

 

This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Gérald Raverot
Gérald Raverot
(France)
Head of the Endocrine Department of Hospices, Professor of Endocrinology, Civils of Lyon and the Lyon’s Pituitary, France

Professor Gérald Raverot is an endocrinologist at Lyon University Hospital and Professor of Endocrinology at Lyon University, France.  He is head of the Endocrine Department of Hospices Civils of Lyon and the Lyon’s Pituitary, center recognized as one of French Reference Center for Pituitary Rare Diseases (HYPO) and European Reference Network on Rare Endocrine Conditions (Endo-ERN).

 

He leads a research team dedicated to “Pathophysiology of pituitary tumour” at the INSERM Research Center U1052. His major research interests are pituitary tumour pathogenesis and identification of markers of aggressiveness allowing the identification of potential new therapies. He is the chair of the Special Interest Group on aggressive pituitary tumours and of the European Society of Endocrinology guidelines on aggressive pituitary tumours and carcinoma.

 

Dr Raverot is president of the French Society of Endocrinology, ExCO member of the European NeuroEndocrinology Association (ENEA), member of the educational committee of the European Society of Endocrinology.

properties.alt

Gudmundur Johannsson (Sweden)

Professor of Endocrinology, Deputy Dean and Honorary Consultant at the Department of Endocrinology at Sahlgrenska University Hospital, Gothenburg, Sweden


Gudmundur Johannsson is a Professor of Endocrinology and Deputy Dean at the Sahlgrenska Academy, University of Gothenburg and an Honorary Consultant at the Department of Endocrinology at Sahlgrenska University Hospital, Gothenburg, Sweden.

 

Professor Johannsson received his medical degree from the University of Iceland, Reykjavik, Iceland, and training in internal medicine and clinical endocrinology at Sahlgrenska University Hospital.

 

He defended his thesis, which focused on growth hormone replacement in adults with hypopituitarism, in 1997. In 2003 he became a Senior Lecturer and progressed to Professor of Endocrinology in 2010, all at the Sahlgrenska Academy. He was head of Department of Endocrinology at the Sahlgrenska University Hospital between 2000 and 2011 and Co-Director, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine between 2015-2018, and Deputy Head Institute of Medicine, Sahlgrenska Academy, University of Gothenburg between 2018-2023. He was a Visiting Professor at the University of New South Wales, Sydney from 2001 to 2003.

 

Professor Johansson’s major research interests include pituitary and adrenal diseases. He is past president of the Growth Hormone Research Society, board member of the Pituitary Society, member of the steering committee of European Reference Network on Rare Endocrine Conditions, and serves on the Editorial Board of several international scientific journals. Professor Johannsson has more than 300 publications in peer-reviewed journals.


Read full bio